Cava: Uncommon Presentation of Antiphospholipid Syndrome Recurrent Intestinal Perforation Associated with Thrombosis of Inferior Vena

3. Information on permissions/orders of reprints in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working is a monthly international serial edited by Earl D.

[1]  K. Pritzker.  Crystal deposition in joints: prevalence and relevance for arthritis. , 2008, The Journal of rheumatology.

[2]  D. Owen,et al.  Granulomatous hepatitis associated with etanercept therapy. , 2008, The Journal of rheumatology.

[3]  M. Khamashta,et al.  The abdominal manifestations of the antiphospholipid syndrome. , 2007, Rheumatology.

[4]  X. Puéchal.  Antineutrophil cytoplasmic antibody-associated vasculitides. , 2007, Joint, bone, spine : revue du rhumatisme.

[5]  Y. Shoenfeld,et al.  Antiphospholipid syndrome dilemmas still to be solved: 2008 status , 2007, Annals of the rheumatic diseases.

[6]  L. Gorospe,et al.  Wegener's granulomatosis mimicking a thoracic spondylodiscitis. , 2007, The Journal of rheumatology.

[7]  P. Cervera,et al.  Thoracic spinal cord compression indicating Wegener's granulomatosis in a patient with a previous presumptive diagnosis of microscopic polyangiitis. , 2007, Joint, bone, spine : revue du rhumatisme.

[8]  G. Espinosa,et al.  Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. , 2007, Seminars in arthritis and rheumatism.

[9]  F. Rosendaal,et al.  No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. , 2007, Archives of internal medicine.

[10]  Richard W. Martin,et al.  Outcome measurements in scleroderma: results from a delphi exercise. , 2007, The Journal of rheumatology.

[11]  M. Hershfield,et al.  Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout. , 2007, Arthritis and rheumatism.

[12]  Ji-Hua Liu,et al.  The upper thoracic spinal cord compression as the initial manifestation of Wegener’s granulomatosis: a case report , 2007, European Spine Journal.

[13]  A. Barrier,et al.  Diffuse large and small bowel necrosis in catastrophic antiphospholipid syndrome. , 2006, European journal of gastroenterology & hepatology.

[14]  E. Cogan,et al.  Wegener's granulomatosis masquerading as a renal cancer: a case report and review of the literature. , 2006, Clinical and experimental rheumatology.

[15]  D. Scott,et al.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies , 2006, Annals of the rheumatic diseases.

[16]  P Netter,et al.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.

[17]  P Netter,et al.  EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.

[18]  H. Moutsopoulos,et al.  The management of Sjögren's syndrome , 2006, Nature Clinical Practice Rheumatology.

[19]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[20]  T. Neogi,et al.  Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. , 2006, Clinical and experimental rheumatology.

[21]  Y. Takagi,et al.  MR microscopy of the parotid glands in patients with Sjogren's syndrome: quantitative MR diagnostic criteria. , 2005, AJNR. American journal of neuroradiology.

[22]  A. Kavanaugh,et al.  Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial , 2005, Annals of the rheumatic diseases.

[23]  J. Stone,et al.  The antineutrophil cytoplasmic antibody-associated vasculitides. , 2004, The American journal of medicine.

[24]  G. Hughes,et al.  Antiphospholipid (Hughes) Syndrome , 2004, Autoimmunity.

[25]  Y. Takagi,et al.  Cevimeline gargle for the treatment of xerostomia in patients with Sjögren’s syndrome , 2004, Annals of the rheumatic diseases.

[26]  Elizabeth W Karlson,et al.  Purine-rich foods, dairy and protein intake, and the risk of gout in men. , 2004, The New England journal of medicine.

[27]  James E. Evans,et al.  Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.

[28]  N. Kocer,et al.  MR imaging findings of spinal dural involvement with Wegener granulomatosis. , 2002, AJNR. American journal of neuroradiology.

[29]  E. Tindall,et al.  Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. , 2002, Archives of internal medicine.

[30]  Hirotaka Matsuo,et al.  Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.

[31]  P. Dartevelle,et al.  Occlusion of the Aorta and Inferior Vena Cava in a Patient with Circulating Anticoagulants , 2002, Annals of vascular surgery.

[32]  M. Fischer,et al.  The antiphospholipid syndrome. , 2002, Seminars in nephrology.

[33]  Stanley B. Cohen,et al.  A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. , 2002, Arthritis and rheumatism.

[34]  T. Medsger,et al.  Improvement in skin thickening in systemic sclerosis associated with improved survival. , 2001, Arthritis and rheumatism.

[35]  N. Bellamy,et al.  A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. , 2001, Arthritis and rheumatism.

[36]  S. Silverman,et al.  Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. , 2001, Radiology.

[37]  M. Dalakas.  Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. , 1999, Muscle & nerve.

[38]  V. Park,et al.  Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. , 1999, Fertility and sterility.

[39]  A. Clark,et al.  Clinical uses of intravenous immunoglobulin in pregnancy. , 1999, Clinical obstetrics and gynecology.

[40]  W. Petritsch,et al.  Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease , 1999, Digestive Diseases and Sciences.

[41]  J. Ray,et al.  Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. , 1998, Archives of internal medicine.

[42]  K. Eguchi,et al.  Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren’s syndrome , 1998, Annals of the rheumatic diseases.

[43]  R. Falk,et al.  Small-vessel vasculitis. , 1997, The New England journal of medicine.

[44]  F. V. D. van den Hoogen,et al.  Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. , 1996, British journal of rheumatology.

[45]  E. Atra,et al.  Juvenile dermatomyositis and pregnancy: report and literature review. , 1992, The Journal of rheumatology.

[46]  J. Dancis,et al.  The transfer and metabolism of corticosteroids in the perfused human placenta. , 1978, American journal of obstetrics and gynecology.

[47]  C. Gieger,et al.  SLC2A9 influences uric acid concentrations with pronounced sex-specific effects , 2008, Nature Genetics.

[48]  R. Cervera,et al.  Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic? , 2008, Autoimmunity reviews.

[49]  G. Hughes.  Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons. , 2008, Autoimmunity reviews.

[50]  Chan Jun-mi,et al.  International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .

[51]  B. Thiers.  Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Systematic Review , 2008 .

[52]  J. Stockman,et al.  Febuxostat Compared with Allopurinol in Patients With Hyperuricemia and Gout , 2007 .

[53]  M. Qari,et al.  Recurrent intestinal perforations as a presentation of antiphospholipid syndrome , 2006, Annals of Saudi medicine.

[54]  N. Ishii,et al.  Dermatomyositis and pregnancy. Case report and review of the literature. , 1991, Dermatologica.